Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | MB | P02144 | 1/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8611481 | 0.87 | MEN1 (0.63) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL1403606 | 0.84 | MEN1 (0.56) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL13715092 | 0.84 | SRC (0.47) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL17144199 | 0.83 | SRC (0.55) | MEN1KMT2ASMN1; SMN2L3MBTL1CA1 | |
| SCHEMBL907017 | 0.83 | RXFP1 (0.53) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL11297176 | 0.81 | KMT2A (0.67) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL3650502 | 0.81 | POLB (0.49) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL12245467 | 0.81 | KMT2A (0.71) | MEN1KMT2ATDP1LMNACYP1A2 | |
| SCHEMBL3900754 | 0.80 | ALDH1A1 (0.53) | MEN1KMT2ALMNACA1CA2 | |
| SCHEMBL23098267 | 0.80 | HSD17B10 (0.56) | MEN1KMT2ATDP1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117136307-A | Methods, assays and systems for detecting target analytes | 索伦托治疗有限公司 | 2023-11-28 | — | — | CN | claimed |
| EP-4278183-A1 | METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE | Sorrento Therapeutics, Inc. (US) | 2023-11-22 | — | — | EP | claimed |
| WO-2022155380-A1 | METHODS, ASSAYS AND SYSTEMS FOR DETECTION OF A TARGET ANALYTE | VIREX HEALTH, INC. (US) | 2022-07-21 | — | — | WO | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | claimed |
| EP-3122756-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | claimed |
| CN-101395473-A | Water-soluble conjugates for electrochemical detection | INVILLNIS MEDICINE SWISS CO LT (CH) | 2009-03-25 | — | — | CN | claimed |
| WO-2007123507-A1 | WATER-SOLUBLE CONJUGATES FOR ELECTROCHEMICAL DETECTION | INVERNESS MEDICAL SWITZERLAND GMBH (CH) | 2007-11-01 | — | — | WO | claimed |
| US-20060205090-A1 | Water-soluble conjugates for electrochemical detection | OAKVILLE HONG KONG COMPANY LIMITED (HK) | 2006-09-14 | — | — | US | claimed |
| EP-0759171-B1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES (GB) | 1998-04-15 | — | — | EP | claimed |
| EP-0759171-A1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1997-02-26 | — | — | EP | claimed |
| US-5602277-A | Substituted benzene derivatives useful as neuraminidase inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 1997-02-11 | — | — | US | claimed |
| WO-1996030329-A1 | SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INCORPORATED (US) | 1996-10-03 | — | — | WO | claimed |
| WO-1995031724-A1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1995-11-23 | — | — | WO | claimed |
| US-4322410-A | P-Acetaminophenyl phosphate salts as analgesics and antipyretics | Dugniolle, Jacques (FR) | 1982-03-30 | — | — | US | claimed |
| US-12607589-B2 | Methods, assays and systems for detection of a target analyte | SORRENTO THERAPEUTICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-4322410-A | P-Acetaminophenyl phosphate salts as analgesics and antipyretics | Dugniolle, Jacques (FR) | 1982-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | MEN1 1681/4885KMT2A 3120/4885TDP1 3934/4885 |
| US-12607589-B2 | Methods, assays and systems for detection of a target analyte | PRSS3, PRSS2, ZP1 | MEN1 3062/4885KMT2A 3740/4885TDP1 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.